Literature DB >> 21367449

Maintenance of phenotype and function of cryopreserved bone-derived cells.

Shaoyi Wang1, Jun Zhao, Wenjie Zhang, Dongxia Ye, Wenwen Yu, Chao Zhu, Xiuli Zhang, Xiaojuan Sun, Chi Yang, Xinquan Jiang, Zhiyuan Zhang.   

Abstract

The emerging fields of tissue engineering and regenerative medicine require large numbers of cells for therapy. Although the properties of cells obtained from a variety of fresh tissues have been delineated, the knowledge regarding cryopreserved grafts-derived cells remains elusive. Previous studies have shown that living cells could be isolated from cryopreserved bone grafts. However, whether cryopreserved bone-derived cells can be applied in regenerative medicine is largely unknown. The present study was to evaluate the potential application of cryopreserved grafts-derived cells for tissue regeneration. We showed that cells derived from cryopreserved bone grafts could maintain good proliferation activity and osteogenic phenotype. The biological phenotype of these cells could be well preserved. The transplantation of cryopreserved bone-derived cells on scaffold could promote new bone formation in nude mice and enhance the osteointegration for dental implants in canine, which confirmed their osteogenic capacity, and showed that cells derived from cryopreserved bone were comparable to that of fresh bone in terms of the ability to promote osteogenesis in vivo. This work demonstrates that cryopreserved bone grafts may represent a novel, accessible source of cells for tissue regeneration therapy, and the results of our study may also stimulate the development of other cryopreservation techniques in basic and clinical studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367449     DOI: 10.1016/j.biomaterials.2011.01.020

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Bone regeneration by stem cell and tissue engineering in oral and maxillofacial region.

Authors:  Zhiyuan Zhang
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

2.  Injectable bone tissue engineering using expanded mesenchymal stem cells.

Authors:  Yoichi Yamada; Sayaka Nakamura; Kenji Ito; Eri Umemura; Kenji Hara; Tetsuro Nagasaka; Akihiro Abe; Shunsuke Baba; Yasushi Furuichi; Yuichi Izumi; Ophir D Klein; Toshihiko Wakabayashi
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

3.  Injectable osteogenic microtissues containing mesenchymal stromal cells conformally fill and repair critical-size defects.

Authors:  Ramkumar T Annamalai; Xiaowei Hong; Nicholas G Schott; Gopinath Tiruchinapally; Benjamin Levi; Jan P Stegemann
Journal:  Biomaterials       Date:  2019-04-04       Impact factor: 12.479

4.  The bone-forming effects of HIF-1α-transduced BMSCs promote osseointegration with dental implant in canine mandible.

Authors:  Duohong Zou; Jiacai He; Kai Zhang; Jiewen Dai; Wenjie Zhang; Shaoyi Wang; Jian Zhou; Yuanliang Huang; Zhiyuan Zhang; Xinquan Jiang
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect.

Authors:  Shaoyi Wang; Mengyu Li; Wenjie Zhang; Hongfei Hua; Ningtao Wang; Jun Zhao; Jing Ge; Xinquan Jiang; Zhiyuan Zhang; Dongxia Ye; Chi Yang
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.